190 related articles for article (PubMed ID: 3500211)
1. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
2. B5, a new B cell-restricted activation antigen.
Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
[TBL] [Abstract][Full Text] [Related]
3. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
Freeman GJ; Freedman AS; Segil JM; Lee G; Whitman JF; Nadler LM
J Immunol; 1989 Oct; 143(8):2714-22. PubMed ID: 2794510
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation.
Tseng CT; Springgate CF; Tadmori W; Choi YS
J Immunol; 1988 Apr; 140(7):2305-11. PubMed ID: 2450917
[TBL] [Abstract][Full Text] [Related]
5. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
Wilson JL; Cunningham AC; Kirby JA
Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
[TBL] [Abstract][Full Text] [Related]
6. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
7. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
Boyd AW; Anderson KC; Freedman AS; Fisher DC; Slaughenhoupt B; Schlossman SF; Nadler LM
J Immunol; 1985 Mar; 134(3):1516-23. PubMed ID: 3871451
[TBL] [Abstract][Full Text] [Related]
8. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
9. Cell surface antigens expressed by subsets of pre-B cells and B cells.
McKearn JP; Baum C; Davie JM
J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
[TBL] [Abstract][Full Text] [Related]
10. Identification of an early activation antigen (Bac-1) on human B cells.
Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
[TBL] [Abstract][Full Text] [Related]
11. A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells.
Nozawa Y; Wachi E; Tominaga K; Abe M; Wakasa H
J Pathol; 1993 Mar; 169(3):309-15. PubMed ID: 8492223
[TBL] [Abstract][Full Text] [Related]
12. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
13. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
14. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
[TBL] [Abstract][Full Text] [Related]
15. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody.
Powers GD; Faherty DA; Connaughton SE; Biondi DA; Godfrey DI; Gault A; Chen CY; Nabavi N
Cell Immunol; 1994 Feb; 153(2):298-311. PubMed ID: 7509723
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
19. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
[TBL] [Abstract][Full Text] [Related]
20. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
